Efficacy of Dual Orexin Receptor Antagonists in Hypnotic-Naive Patients with Insomnia

未提供0 个研究点目标入组 400 人开始时间: 待定

适应症

试验速览

暂无简介。

•New patients aged >18 years who were diagnosed with insomnia, had no prior history of hypnotic treatment, and received suvorexant or lemborexant for the first time.

•Patients who received suvorexant (SUV) or lemborexant (LEM) in a manner inconsistent with the approved prescribing information.
•Patients with any contraindication to SUV or LEM.
•Patients who regularly used sedating antidepressants (mirtazapine, mianserin, or trazodone) or antipsychotics (immediate-release quetiapine, extended-release quetiapine, olanzapine, risperidone, asenapine, or typical antipsychotics) after dinner or at bedtime during treatment with SUV or LEM.
•Patients with a history of hypnotic use.
•Patients with specific sleep disorders other than insomnia, such as periodic limb movement disorder, restless legs syndrome, or circadian rhythm sleep-wake disorders.
•Patients with narcolepsy or cataplexy.
•Patients who declined participation in the study through the opt-out process.

发起方

未提供